Published Apr 13, 2020
#324 Gvoke Glucagon
Join Scott Benner as he delves into the career journey and innovative impact of Paul Edick, CEO of Xeris, with a focus on the revolutionary development of Gvoke, a groundbreaking liquid stable glucagon for severe hypoglycemia, and the evolving landscape of patient-centered diabetes management.
Topics covered
Popular Clips
Questions from this episode
- Asked by 50 people
Episode Highlights
Related Episodes
#385 Gvoke HypoPen
Answers 383 questions
#1029 Glucagon Story: Sarah
Answers 383 questions
#1044 Glucagon Story: Heather
Answers 383 questions
#789 Important Things to Know About Gvoke HypoPen® (glucagon injection)
Answers 383 questions
#987 Glucagon Story: Aimee
Answers 383 questions#301 Diabetes Pro Tip: Glucagon and Low BGs
Answers 383 questions#301 Diabetes Pro Tip: Glucagon and Low BGs
Answers 383 questions#1014 Diabetes Pro Tip: Glucagon & Low BGs (Remastered)
Answers 383 questions
#308 Psyco-glycemia
Answers 383 questions
#617 Glucommander
Answers 383 questions
#386 Podfather
Answers 383 questions
#443 Type 1 Clinical Trials
Answers 383 questions
#803 The Conversation Reveals All
Answers 383 questions
#233 A Rose By Any Other Name
Answers 383 questions
#1015 Diabetes Pro Tip: Emergency Room Protocols (Remastered)
Answers 383 questions